|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Product revenue, net | |||||
| Product revenue, net | |||||
| Royalty, contract and other revenue | |||||
| Total product revenue, net | |||||
| Costs and expenses: | |||||
| Cost of goods sold | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of intangible assets | |||||
| Total costs and expenses | |||||
| Income (loss) from operations | |||||
| Other income (expense): | |||||
| Interest and other income | |||||
| Loss on debt extinguishment, net | |||||
| Debt refinancing costs | |||||
| Interest expense | |||||
| Change in fair value of warrants | |||||
| Change in fair value of contingent value rights | |||||
| Total other expense | |||||
| Net income (loss) before income taxes | |||||
| Income tax benefit | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Unrealized gains (losses) on investments | |||||
| Comprehensive income (loss) | |||||
| Net loss per common share - basic (in dollars per share) | |||||
| Net loss per common share - Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding - basic (in shares) | |||||
| Weighted average common shares outstanding - Diluted (in shares) | |||||
| Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | |||||
Loading...